These are the projects COGEM is currently working on. Research projects are performed by third parties. The date is the estimated date at which the project will be completed.
A joint publication bij The Health Council of the Netherlands and the Netherlands Commission on Genetic Modification (COGEM)
In November 2015 The Health Council and COGEM organized an international meeting (Genome on Demand) on the potential use of CRISPR/Cas9 technology to edit the human genome.
The upcoming report is in sequel to this meeting. In the report the technical, legal and ethical aspects of germline modification in humans will be explored and discussed.
De COGEM was asked to advise on the environmental risks of import and processing of genetically modified (GM) maize 1507xNK603. This line expresses the genes cry1F, pat en cp4 epsps, which confer insect resistance and herbicide tolerance to the crop.
COGEM has been asked to advise on the environmental risks of import and processing of genetically modified (GM) maize MON89034x1507xMON88017x59122xDAS-40278-9 . This line contains the genes cry1A.105, cry2Ab2, cry1F, cry3Bb1, cry34Ab1, cry35Ab1, pat, cp4-epsps and aad-1, conferring insect resistance and herbicide tolerance to the crop.